These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 9756358)

  • 1. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
    Sutor B; Mantell K; Bacher B
    Neurosci Lett; 1998 Aug; 252(1):57-60. PubMed ID: 9756358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
    Lugnier C; Gauthier C; Le Bec A; Soustre H
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.
    Bode DC; Hamel LT; Wax MB
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1286-91. PubMed ID: 8263791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in phosphodiesterase activity in the developing rat submandibular gland.
    Tanaka S; Shimooka S; Shimomura H
    Arch Oral Biol; 2002 Aug; 47(8):567-76. PubMed ID: 12221013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and pharmacological characterization of cyclic nucleotide phosphodiesterase in airway epithelium.
    Rousseau E; Gagnon J; Lugnier C
    Mol Cell Biochem; 1994 Nov; 140(2):171-5. PubMed ID: 7898488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ; Cieslinski LB
    Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplicity within cyclic nucleotide phosphodiesterases.
    Rybalkin SD; Beavo JA
    Biochem Soc Trans; 1996 Nov; 24(4):1005-9. PubMed ID: 8968501
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Lugnier C; Schini VB
    Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concanavalin A stimulates the Rolipram-sensitive isoforms of cyclic nucleotide phosphodiesterase in rat thymic lymphocytes.
    Valette L; Prigent AF; Némoz G; Anker G; Macovschi O; Lagarde M
    Biochem Biophys Res Commun; 1990 Jun; 169(3):864-72. PubMed ID: 2163636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
    Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
    Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
    Bellamy TC; Garthwaite J
    Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE; Lakey T; Houslay MD
    Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
    Kireeva NN; Bobruskin ID; Severin SE
    Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
    Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
    J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
    Souness JE; Diocee BK; Martin W; Moodie SA
    Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High activity of low-Michaelis-Menten constant 3', 5'-cyclic adenosine monophosphate-phosphodiesterase isozymes in renal inner medulla of mice with hereditary nephrogenic diabetes insipidus.
    Takeda S; Lin CT; Morgano PG; McIntyre SJ; Dousa TP
    Endocrinology; 1991 Jul; 129(1):287-94. PubMed ID: 1647298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calmodulin regulation of testicular cyclic nucleotide phosphodiesterases.
    Purvis K; Hansson V
    Int J Androl; 1980 Dec; 3(6):713-8. PubMed ID: 6259062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.